Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
O'Melveny is well known for bringing Chinese life sciences and biotech companies to the public markets in Hong Kong and the US. The China life sciences and healthcare practice also covers IP and licensing matters, along with M&A, private equity, and venture capital transactions. The lead partner for the China capital markets team, Ke Geng in Beijing advises on pharmaceutical, biotech and life sciences-related IPOs and equity financings in China. Ke Zhu is a capital markets specialist in Hong Kong.
L’éditorial du Legal 500
Clients clés
- Acotec Scientific
- Adlai Nortye
Points forts
- Advised Acotec Scientific on a voluntary partial offer by Boston Scientific Group.
- Advised Adlai Nortye on its Nasdaq IPO.